Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (121-130 of 216) with videos related to

Pageof 22
Sort By:
The Lancet. Oncology|December 19, 2015
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical interventionMaria-Pia Bernardi, Samuel Y Ngan, Michael Michael, et al.
British Journal of Cancer|March 20, 2022
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosingSarah Glewis, Marliese Alexander, Muhammad N H Khabib, et al.
Vaccines|February 28, 2023
Factors Contributing to Chronic Kidney Disease following COVID-19 Diagnosis in Pre-Vaccinated Hospitalized PatientsDiana Laila Ramatillah, Michael Michael, Kashifullah Khan, et al.
Clinical and Translational Science|May 3, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancerSenthil Lingaratnam, Mahek Shah, Joseph Nicolazzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07Bryan H Burmeister, Michael Michael, Elizabeth Burmeister, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2018
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumorsPaul J Wood, Robyn Strong, Grant A McArthur, et al.
Diseases of the Colon and Rectum|September 7, 2019
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional ExperienceVignesh Narasimhan, Maneka Britto, Toan Pham, et al.
Critical Reviews in Oncology/Hematology|July 6, 2012
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factorsStephen J Clarke, Christos S Karapetis, Peter Gibbs, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Clinical characteristics and outcome of primary systemic light-chain amyloidosis in GreeceMichael Michael, Efstathios Kastritis, Sossana Delimpassi, et al.
Annals of Surgical Oncology|April 23, 2021
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative OutcomesJoseph C Kong, Mikael Soucisse, Michael Michael, et al.
Pageof 22

Showing results (121-130 of 216) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|December 19, 2015
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical interventionMaria-Pia Bernardi, Samuel Y Ngan, Michael Michael, et al.
British Journal of Cancer|March 20, 2022
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosingSarah Glewis, Marliese Alexander, Muhammad N H Khabib, et al.
Vaccines|February 28, 2023
Factors Contributing to Chronic Kidney Disease following COVID-19 Diagnosis in Pre-Vaccinated Hospitalized PatientsDiana Laila Ramatillah, Michael Michael, Kashifullah Khan, et al.
Clinical and Translational Science|May 3, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancerSenthil Lingaratnam, Mahek Shah, Joseph Nicolazzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07Bryan H Burmeister, Michael Michael, Elizabeth Burmeister, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2018
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumorsPaul J Wood, Robyn Strong, Grant A McArthur, et al.
Diseases of the Colon and Rectum|September 7, 2019
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional ExperienceVignesh Narasimhan, Maneka Britto, Toan Pham, et al.
Critical Reviews in Oncology/Hematology|July 6, 2012
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factorsStephen J Clarke, Christos S Karapetis, Peter Gibbs, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Clinical characteristics and outcome of primary systemic light-chain amyloidosis in GreeceMichael Michael, Efstathios Kastritis, Sossana Delimpassi, et al.
Annals of Surgical Oncology|April 23, 2021
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative OutcomesJoseph C Kong, Mikael Soucisse, Michael Michael, et al.
Pageof 22